Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

NCT03480438

Conditions
B-precursor ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Uniklinik RWTH Aachen Aachen, Germany
  • Charité - Campus Benjamin Franklin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
View all 21 locations
View Trial Details
Completed

A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

NCT01650701

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • CHU Mont-Godinne Yvoir, Belgium
View all 35 locations
View Trial Details
Completed

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389

NCT06812780

Conditions
Digestive System Diseases, Fibrosis, Hemic and Lymphatic Diseases, +14 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Rialto, California, United States
  • Research Site Miami Lakes, Florida, United States
  • Research Site Orlando, Florida, United States
View Trial Details
Completed

A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

NCT05442554

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
View Trial Details

Related conditions